| Primary |
| Gout |
80.0% |
| Heart Transplant |
13.3% |
| Renal Transplant |
6.7% |
|
| Neuropathy Peripheral |
53.8% |
| Pelvic Pain |
30.8% |
| Tachycardia |
7.7% |
| Visual Impairment |
7.7% |
|
| Secondary |
| Gout |
22.2% |
| Abscess |
9.5% |
| Drug Use For Unknown Indication |
9.5% |
| Diabetes Mellitus |
6.3% |
| Gouty Arthritis |
6.3% |
| Pneumonia |
6.3% |
| Suicide Attempt |
6.3% |
| Renal Transplant |
4.8% |
| Blood Uric Acid Increased |
3.2% |
| Helicobacter Infection |
3.2% |
| Multiple Myeloma |
3.2% |
| Osteoarthritis |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Antiinflammatory Therapy |
1.6% |
| Blood Pressure |
1.6% |
| Constipation |
1.6% |
| Convulsion |
1.6% |
| Depression |
1.6% |
| Helicobacter Gastritis |
1.6% |
|
| Renal Failure Acute |
14.3% |
| Vomiting |
14.3% |
| Completed Suicide |
7.1% |
| Wheezing |
7.1% |
| Cytolytic Hepatitis |
3.6% |
| Hepatocellular Injury |
3.6% |
| Myoglobinuria |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Oedema Peripheral |
3.6% |
| Oxygen Saturation Decreased |
3.6% |
| Polyneuropathy |
3.6% |
| Small Intestine Ulcer |
3.6% |
| Suicide Attempt |
3.6% |
| Systemic Inflammatory Response Syndrome |
3.6% |
| Thrombocytopenia |
3.6% |
| Tremor |
3.6% |
| Urinary Incontinence |
3.6% |
| Weight Decreased |
3.6% |
| Weight Increased |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
|
| Concomitant |
| Gout |
20.3% |
| Pulmonary Arterial Hypertension |
8.1% |
| Hypertension |
7.3% |
| Drug Use For Unknown Indication |
5.7% |
| Multiple Myeloma |
5.7% |
| Mantle Cell Lymphoma |
4.9% |
| Atrial Fibrillation |
4.1% |
| Diabetes Mellitus |
4.1% |
| Iron Deficiency Anaemia |
4.1% |
| Multiple Sclerosis |
4.1% |
| Plasma Cell Myeloma |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Type 2 Diabetes Mellitus |
4.1% |
| Kidney Transplant Rejection |
3.3% |
| Myelodysplastic Syndrome |
3.3% |
| Renal Failure Chronic |
3.3% |
| Bladder Cancer |
2.4% |
| Chronic Myeloid Leukaemia |
2.4% |
| Depression |
2.4% |
| Metastatic Renal Cell Carcinoma |
2.4% |
|
| Vomiting |
13.9% |
| Renal Failure |
8.3% |
| Renal Failure Acute |
8.3% |
| Nausea |
5.6% |
| Pyrexia |
5.6% |
| Rhabdomyolysis |
5.6% |
| Vertigo |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Oedema Peripheral |
4.2% |
| Palpitations |
4.2% |
| Tremor |
4.2% |
| Urinary Retention |
4.2% |
| Urticaria |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Creatinine Renal Clearance Decreased |
2.8% |
| Pulmonary Embolism |
2.8% |
| Renal Impairment |
2.8% |
| Restlessness |
2.8% |
| Thrombocytopenia |
2.8% |
| Toxic Epidermal Necrolysis |
2.8% |
|
